Recombinant Infectious Bursal Disease Virus Carrying Hepatitis C Virus Epitopes
- 1 February 2011
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (3), 1408-1414
- https://doi.org/10.1128/jvi.01391-10
Abstract
The delivery of foreign epitopes by a replicating nonpathogenic avian infectious bursal disease virus (IBDV) was explored. The aim of the study was to identify regions in the IBDV genome that are amenable to the introduction of a sequence encoding a foreign peptide. By using a cDNA-based reverse genetics system, insertions or substitutions of sequences encoding epitope tags (FLAG, c-Myc, or hepatitis C virus epitopes) were engineered in the open reading frames of a nonstructural protein (VP5) and the capsid protein (VP2). Attempts were also made to generate recombinant IBDV that displayed foreign epitopes in the exposed loops (P BC and P HI ) of the VP2 trimer. We successfully recovered recombinant IBDVs expressing c-Myc and two different virus-neutralizing epitopes of human hepatitis C virus (HCV) envelope glycoprotein E in the VP5 region. Western blot analyses with anti-c-Myc and anti-HCV antibodies provided positive identification of both the c-Myc and HCV epitopes that were fused to the N terminus of VP5. Genetic analysis showed that the recombinants carrying the c-Myc/HCV epitopes maintained the foreign gene sequences and were stable after several passages in Vero and 293T cells. This is the first report describing efficient expression of foreign peptides from a replication-competent IBDV and demonstrates the potential of this virus as a vector.This publication has 30 references indexed in Scilit:
- Replication and packaging of an infectious bursal disease virus segment A-derived minigenomeVirus Research, 2008
- The structure of a birnavirus polymerase reveals a distinct active site topologyProceedings of the National Academy of Sciences of the United States of America, 2007
- The 2.6-Angstrom Structure of Infectious Bursal Disease Virus-Derived T=1 Particles Reveals New Stabilizing Elements of the Virus CapsidJournal of Virology, 2006
- Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjectsVaccine, 2006
- The Birnavirus Crystal Structure Reveals Structural Relationships among Icosahedral VirusesCell, 2005
- VP1 of infectious bursal disease virus is an RNA-dependent RNA polymeraseJournal of General Virology, 2004
- Newcastle Disease Virus (NDV) Marker Vaccine: an Immunodominant Epitope on the Nucleoprotein Gene of NDV Can Be Deleted or Replaced by a Foreign EpitopeJournal of Virology, 2002
- C Terminus of Infectious Bursal Disease Virus Major Capsid Protein VP2 Is Involved in Definition of the T Number for Capsid AssemblyJournal of Virology, 2001
- A non-canonical Lon proteinase lacking the ATPase domain employs the Ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virusThe EMBO Journal, 2000
- Potential Use of Poliovirus as a VectorBiologicals, 1993